BUCKINGHAMSHIRE, U.K., Aug. 5, 2003 (PRIMEZONE) -- Amersham plc (LSE:AHM) (NYSE:AHM) (OSE:AHM) today announces the appointment to the Board of Directors of Mr. David Challen as a Non-Executive Director, with immediate effect. David Challen, 60, is currently vice-chairman, European Investment Bank at Citigroup, and previously served as Co-Chairman at Schroder Salomon Smith Barney following the merger of Schroder's Investment Banking business where David had served in many senior positions over a 28-year period before being elected Chairman in 1997.
Mr. Donald Brydon, Chairman, Amersham plc, said, "I am delighted to welcome David to the Amersham Board. David's extensive experience of advising boards of major companies, his financial know-how and international business experience will complement the considerable technical and scientific expertise on Amersham's Board."
Amersham plc (LSE:AHM) (NYSE:AHM) (OSE:AHM) is a world leader in medical diagnostics and in life sciences. Headquartered in the UK, the company had sales of Pounds 1.62 billion in 2002 and has 10,000 employees worldwide. Its strategy is to build its position as a leading provider of products and technologies enabling disease to be better understood, diagnosed earlier and treated more effectively. Amersham -- bringing vision to medical discovery For more information, visit our website at www.amersham.com